The CVC invites researchers and clinicians who are involved in cancer immunotherapeutics at DFCI and affiliated Harvard institutions to become involved in future cancer vaccine trials.
We encourage pharma and biotechnology companies with relevant antibodies, adjuvants or other immune modifiers to participate in our translational efforts. For information on company collaborations please contact: firstname.lastname@example.org.
Collaborations with scientists at academic and hospital centers are ongoing. Physicians with knowledge of patients who would like to learn more about our clinical vaccine trials may contact: email@example.com.